Reference Standards

OncoSpot™ NGS Spike-in Reference Standards

Genecopoeia provides OncoSpot™ NGS Spike-in Reference Standards for monitoring the whole process of the detection. The CRISPR method is employed to modify the genome of tumour cells, introducing single nucleotide mutations or in-frame indel mutations. Concurrently, spike-in markers are set up using our patented technology ‘DNA reference standard and use thereof’.
read more

OncoSpot™ NGS Reference Standards

*Promotions are valid in the US & Canada only. For international customers, please contact your local distributors. Discounts are not valid on previous purchases and cannot be combined with additional discounts. [tab:Product] GeneCopoeia's OncoSpot™ NGS...
read more

OncoSpot™ NGS Spike-in Reference Standards

Genecopoeia provides OncoSpot™ NGS Spike-in Reference Standards for monitoring the whole process of the detection. The CRISPR method is employed to modify the genome of tumour cells, introducing single nucleotide mutations or in-frame indel mutations. Concurrently, spike-in markers are set up using our patented technology ‘DNA reference standard and use thereof’.

read more